ASCENDIS PHARMA A/S - ADR SPONSORED ADR is a security (CUSIP 04351P101) tracked across SEC portfolio filings. 204 institutional managers reported $11.4B on Form 13F as of 2026-06-30; 27 registered fund positions totaling $779.0M via N-PORT as of 2026-03-31.
Showing 15 of 204 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Boston, MA | $2.4B | 10,281,496 |
| Avoro Capital Advisors LLC | New York, NY | $1.2B | 5,062,500 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | BOSTON, MA | $1.1B | 4,813,440 |
| FMR LLC | BOSTON, MA | $886.7M | 3,876,601 |
| Artisan Partners Limited Partnership | Milwaukee, WI | $738.8M | 3,230,188 |
| FRANKLIN RESOURCES INC | San Mateo, CA | $469.3M | 2,051,948 |
| Capital International Investors | Los Angeles, CA | $448.0M | 1,958,843 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $402.0M | 1,757,633 |
| PERCEPTIVE ADVISORS LLC | NEW YORK, NY | $350.3M | 1,531,421 |
| AMERICAN CENTURY COMPANIES INC | KANSAS CITY, MO | $319.6M | 1,397,119 |
| Capital World Investors | LOS ANGELES, CA | $206.0M | 900,517 |
| BlackRock, Inc. | New York, NY | $151.2M | 661,054 |
| Polar Capital Holdings Plc | London, X0 | $149.1M | 651,712 |
| MORGAN STANLEY | NEW YORK, NY | $138.7M | 606,348 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $129.5M | 566,192 |
Showing 15 of 27 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Mid-Cap Growth Fund, Inc. | T. ROWE PRICE MID-CAP GROWTH FUND, INC. | $179.2M | 79.54% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $154.7M | 141.98% |
| SMALLCAP World Fund Inc | SMALLCAP World Fund Inc | $132.5M | 16.35% |
| New Perspective Fund | New Perspective Fund | $106.0M | 6.94% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $68.0M | 53.25% |
| Janus Henderson Venture Fund | JANUS INVESTMENT FUND | $33.0M | 107.71% |
| Bridge Builder Tax Managed Small/Mid Cap Fund | Bridge Builder Trust | $29.0M | 95.77% |
| AZL T Rowe Price Capital Appreciation Fund | Allianz Variable Insurance Products Trust | $16.9M | 192.41% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $9.4M | 141.92% |
| Liberty All-Star Growth Fund | LIBERTY ALL STAR GROWTH FUND INC. | $9.2M | 271.73% |
| SA Wellington Capital Appreciation Portfolio | ANCHOR SERIES TRUST | $8.5M | 42.23% |
| Schwab Select Large Cap Growth Fund | LAUDUS TRUST | $7.4M | 37.42% |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | $4.7M | 11.13% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $3.9M | 34.07% |
| Small Cap Core Portfolio | Bernstein Fund Inc | $3.2M | 45.43% |